EX-10.1
from 10-Q
4 pages
SpringWorks Therapeutics, Inc. Third Amended and Restated Non-Employee Director Compensation Policy This Amended and Restated Non-Employee Director Compensation Policy (The “Policy”) Dated February 23, 2023 (The “Effective Date”) of SpringWorks Therapeutics, Inc., a Delaware Corporation (The “Company”) Amends and Restates the Previous Non-Employee Director Compensation Policy Which Became Effective on February 23, 2022. the Purpose of the Policy Is to Provide a Total Compensation Package That Enables the Company to Attract and Retain, on a Long-Term Basis, High- Caliber Directors Who Are Not Employees or Officers of the Company. This Policy Will Apply to All Non- Employee Directors of the Board (Such Directors, the “Eligible Directors”) of the Company (The “Board”). in Furtherance of This Purpose, Except as Otherwise Provided in Any Written Agreement Between the Company and an Eligible Director, All Eligible Directors Shall Be Paid Compensation for Services Provided to the Company as Set Forth Below: Cash Retainers Annual Retainer for Board Membership: $45,000 for General Availability and Participation in Meetings and Conference Calls of Our Board. No Additional Compensation for Attending Individual Board Meetings. Additional Annual Retainer for Non-Executive Chair of the Board: $35,000 Additional Annual Retainers for Committee Membership: Audit Committee Chairperson: $20,000 Audit Committee Member: $10,000 Compensation Committee Chairperson: $15,000 Compensation Committee Member: $7,500 Nominating and Corporate Governance Committee Chairperson: $10,000 Nominating and Corporate Governance Committee Member: $5,000 Research and Development Committee Chairperson $15,000 Research and Development Committee Member $7,500 Note: Chair and Committee Member Retainers Are in Addition to Retainers for Members of the Board of Directors
12/34/56
